Login

Farrerol

CAT:
804-HY-N0344-03
Size:
10 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Farrerol - image 1

Farrerol

  • CAS Number: 24211-30-1
  • UNSPSC Description: Farrerol is a bioactive constituent of Rhododendron, with broad activities such as anti-oxidative, anti-inflammatory, anti-tumor, neuroprotective and hepatoprotective effects[1][2][3][4][5][6].
  • Target Antigen: Others
  • Type: Natural Products
  • Related Pathways: Others
  • Applications: COVID-19-immunoregulation
  • Field of Research: Cancer; Inflammation/Immunology; Neurological Disease
  • Assay Protocol: https://www.medchemexpress.com/farrerol.html
  • Purity: 99.98
  • Solubility: DMSO : 250 mg/mL (ultrasonic)
  • Smiles: O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=C(C)C(O)=C(C)C(O)=C13
  • Molecular Weight: 300.31
  • References & Citations: [1]Ran X, et al. Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway. Int J Mol Sci. 2018 Jul 13;19(7).|[2]Cui B, et al. Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line. Biomed Pharmacother. 2019 Jan;109:112-119.|[3]Dai F, et al. Farrerol inhibited angiogenesis through Akt/mTOR, Erk and Jak2/Stat3 signal pathway. Phytomedicine. 2016 Jun 15;23(7):686-93.|[4]Li B, et al. Farrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of epithelial mesenchymal transition. Microb Pathog. 2019 Jun;131:277.|[5]Li Y, et al. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways. Int Immunopharmacol. 2019 Oct;75:105739.|[6]Wang L, et al. Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy. Int J Biol Sci. 2019 Jan 29;15(4):788-799.
  • Shipping Conditions: Room Temperature
  • Storage Conditions: 4°C (Powder, protect from light)
  • Clinical Information: No Development Reported